6 hours ago
11
The residential block at 655 Park Avenue on Manhattan’s Upper East Side is so storied it has its own Wikipedia entry. It has housed luminaries from bestselling romance author Danielle Steel to esteemed yachtsmen and the 20th-century heir William Kissam Vanderbilt II. A more recent resident, on the ground floor, is Alpha Male Plastic Surgery, a clinic offering a broad menu of elective procedures catering to the needs of the modern man.
On a coffee table in the waiting room, fanned-out brochures tout facelifts, non-surgical penile implants, and Tesamorelin – an FDA-approved peptide injection targeting stubborn visceral belly fat. Flatscreen monitors mounted behind the front desk shuffle through ads for a “Full Male Model Makeover”, proprietary procedures like BodyBanking® and the 360 TorsoTuck®, and for the gym rat who habitually skips leg day, even “Amazing New Calves”.
And there’s something new on the menu: a state-of-the-art procedure that employs “cadaveric adipose tissue” – that is, fat harvested from a corpse.
That fat is sterilized, put into tubes and rebranded as a substance called Alloclae. Until now, cosmetic surgeons would use autologous fat transfers, meaning fat is extracted from one part of a person’s body (typically via liposuction), and then re-injected to areas requiring a little more lift. For women: the lips, the breasts and the buttocks. In men, often the pecs, biceps and calves.
But Alloclae means that those who don’t want to remove their own fat – or, in the case of many patients, are lacking in body fat altogether – can now receive a one-off set of injections from external, and crucially, deceased donor sources.
In our peptides-pumping, cosmetic-surgery obsessed world, Alloclae is being marketed as the latest body-buffing hack for anyone seeking to level up their appearance. The process is minimally invasive and largely safe, as long as you can get your head around where that extra va-voom has come from.
“It’s a gamechanger,” says Alpha Male’s surgeon, Dr Douglas Steinbrech. “They [Alloclae recipients] don’t need surgery. They don’t need general anesthesia. They don’t have recovery, and the pain from all that.”
Since early 2025, Alloclae has been most popular among women seeking boob or butt augmentation, but Steinbrech says that men are taking an interest in procedures like this too. He says interest is being driven by souped-up male body standards promoted by the burly heroes of modern Marvel Comics blockbusters, and the current online trend in “looksmaxxing”– which promotes the social importance of “optimizing” physical attractiveness, and has been described as a form of masculinist body dysmorphia.
In the back of Steinbrech’s clinic, a 68-year-old patient (who asks not to be identified by name) is prepping for an Alloclae procedure. Steinbrech calls him a “one-percenter”, as in, he’s in the highest percentile of physical fitness for his demographic. He has a full back, toned arms and a pronounced chest. Still, he’s having 100cc of treated, shelf-stable, room-temperature donor fat, collected sometime in the last six months, injected into his upper pectorals. Carefully deposited into his chest, the Alloclae will, if everything goes according to plan, pass as muscle to the naked eye. “It’s just a little enhancement,” the patient shrugs.
“It’s a common problem,” Steinbrech explains, as he marks up his patient with a magic marker, highlighting the upper chest where he will be injected. “I have all these fit, totally ripped guys that have no fat [for liposuction].” On a nearby tray, eight 12.5cc syringes are arranged, branded with the Alleclae logo, and filled with an opaque, custard yellow goo.
But the use of donated tissue in cosmetic surgery gives rise to a whole range of headier, philosophical questions. Organ and tissue donation has generally been considered a noble offering, a gift from the deceased to a stranger. How do the dead feel about having the fat removed for a boob job?
Plastic surgery clinics once thrived on the removal of fat. Unsightly love handles or excess cellulose was vacuumed out via high-pressure aspirator, and either discarded or grafted on to other parts of the body. Then came Ozempic.
A 2025 Gallup poll reported that about one in every eight Americans are now taking prescribed weight-loss drugs. The rising popularity, and near ubiquity, of GLP-1 medications such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound). It seemed like these drugs could run plastic surgeons out of business, but in fact they have created a sizeable clientele of patients who have lost too much weight. “It’s a huge emerging market,” says Dr Sachin Shridharani, of New York City’s Luxurgery aesthetic surgery clinic, just a short walk from Alpha Male’s offices.
Shridharani was ahead of the curve in identifying this trend. In 2023, he co-authored a paper that appeared in the Aesthetic Surgery Journal that explored the potential wide use for GLP-1 drugs, not just for managing obesity but also cardiovascular health, type 2 diabetes, and even reducing obstructive sleep apnea. All these patients would be shedding large amounts of weight over a relatively short interval, he wrote, producing cosmetic side effects such as loose skin, and decreased fat volume in more desirable areas. He saw an opportunity for cosmetic surgeons to answer that question.
Samantha (who asked that her last name be withheld) is 28 years old and a patient of Shridharani’s. When she started taking GLP-1s meds, she was overweight. After a lifelong struggle with her weight, the drugs helped her finally feel in control. “My body was transforming,” she says. Her clothes started fitting better. Her confidence improved. But as she shed weight, she noticed new physical changes that brought insecurities: “I had loose skin, and contour changes that I wasn’t expecting. I consulted with Dr Shridharani, and he introduced me to Alloclae.”
Initially, Samantha was wary of injecting cadaveric fat. She worried about infections or potentially contracting something from the source donor, about whom she knew nothing. But Shridharani reassured her, she recalls, that Alloclae is “purified, the whole nine yards”. Potential risks and side effects are fairly minimal: redness and bruising at the injection site, temporary soreness and, in very rare cases, hard oil cysts, which are also a risk with autologous fat grafts.
Brochures distributed to curious surgeons and clinicians by Alloclae’s manufacturer, Tiger Aesthetics, purport the products safety and sterility. The purification process is part of what makes Alloclae so innovative, the leaflets claim. Most other allogeneic donations – that is, those drawn from sources outside the patient’s own body – require compatibility. Blood, organ and certain tissue donations require different matching criteria, in order for the receiving patient’s immune system to not identify it as a foreign threat and attack it in turn. To prevent this, Alloclae is kept below what is termed the DNA’s “immunogenicity threshold”. The fat, in the most basic sense, is scrubbed of any traces of the source donor. That way, the patient’s immune system will not trigger the sort of defensive response that a foreign pathogen typically merits.
The product, they claim, is convincingly versatile: injectable anywhere on the body where fat naturally exists, and able to mimic the appearance of natural fat, precisely because it is natural fat. Just natural fat collected from cadavers via tissue banks.
Standard donor forms, like those provided by donor registries such as Donate Life America, make no specific mention of “fat” or “adipose tissue”, they fall under the category of “bone and associated tissue”.
One wonders: would a prospective donor tick that little box while renewing their driver’s license if, say, they knew their adipose tissue was reaped and redeployed for a Brazilian butt lift?
“I can’t answer that question,” laughs Marc Pearce, president and CEO of the American Association of Tissue Banks, a trade organization that promotes and sets standards of tissue donation nationwide. (Tiger Aesthetics sources its fat from tissue banks certified by the AATB.)
Standard donor forms, Pearce says, offer the dead reserve no particular rights when it comes to how and where their eyes, organs or even stubborn belly fat may be reapplied.
There may also be reservations around a product that is still new and lacks long-term medical literature that supports the safety of autologous fat grafts – or even synthetic implants. Dr Glenn Lyle, a board-certified plastic surgeon based in Raleigh, North Carolina, calls Alloclae a “good tool”, and uses it in his practice, but remains circumspect about how eagerly the industry is adopting it. “I think these early adopters need to be publishing more information,” he says. “We’re moving too fast with this. We don’t even have follow-up studies. This is being put in willy-nilly.”
Alloclae is FDA compliant, which is not quite the same as it being FDA approved. Because human fat tissue is considered an existing “product”, it is not subjected to the same standards as cosmetic interventions such as botox, dermal fillers or breast implants. Some doctors, including Lyle, have expressed concerns that Alloclae injected into the breast may complicate routine cancer screenings. “Who’s to say that there aren’t now lumps on mammograms that can’t be distinguished from cancer?” Lyle says. This is mostly an issue with breast implants, he adds: “I’m less concerned with the buttock because no one mammograms the butt.”
Of course, no amount of studies can make injecting cadaveric fat into your own body feel less Swiftian: conjuring, at the more sinister edges of the imagination, visions of bilked blubber purloined from corpses and pumped into problem areas.
On social media, influencers sometimes refer to buttocks injections accomplished via Alloclae as “Zombie BBLs”. Early coverage of the procedure has, likewise, played up the eeriness, with talk of “zombie filler” and “corpse cosmetics”.
But people routinely get bioprosthetic porcine valves from pigs surgically installed to replace diseased human heart valves. And the tissue of living and dead human beings intermingle in all kinds of taken-for-granted ways. Cadaveric bones are recycled in dental grafts. Cadaver tissue – also called “Allografts” – are commonly used in surgically treating ACL tears. Pro athletes such as the NFL’s Aaron Rodgers and English footballer Michael Owen have undergone Allografted ACL repairs.
“There’s always going to be more stigma when something first comes out that’s very avant garde, and is for an aesthetic indication,” says Luxurgery’s Shridharani.
Alloclae’s potential extends beyond elective uses like pec and butt lifts, which may be deemed “vanity” procedures. One of Shridharani’s most successful Alloclae patients was a young woman who suffered a significant injury after a skiing accident. The fallout from her accident required major orthopaedic surgery, including a femur repair and a titanium rod to stabilize her lower leg. No amount of glute workouts or interval training could restore the appearance of her severely damaged hip and buttocks. She says her romantic life and personal intimacy were affected. Then in May 2025 she heard about Alloclae.
She had concerns about the whole cadaver element. “It’s a little bit strange to think about,” says the woman (she asked to retain anonymity). “Am I going to have any side effects? Will there be strange rashes? I was very skeptical.”
Still, she went through with the procedure, precisely because nothing else seemed like it would help fill in those missing contours convincingly (absent her own personal adipose, which was in short supply). “I didn’t want anything super outrageous. I just wanted to return to what I looked like before,” she says.
The woman did not go under general anaesthetic, and was able to walk home through Central Park after the procedure. Some discomfort set in that night, but passed in a few days. “It provided that instant contour,” she says. “And instant gratification – which is what everyone wants these days.”
And beyond repairing hip dips and scarring resulting from ski accidents, Alloeclae’s cosmetic indications can benefit a broad range of patients. Shridharani says it would be possible for him to reconstruct a whole breast out of the product, to aid patients who have lost tissue from mastectomies, without having to resort to the usual silicone fillers or saline implants. Online, other patients have documented cases of having Alloclae injected to treat severe acne scarring.
Dr Aneesh Gupta, a plastic surgeon with practices in Pennsylvania and Maryland, which offer gender-affirming surgeries, believes Alloclae could have potential in such treatments too.
However, he notes that the barrier to the product being widely used in these sorts of procedures is not the quality of Alloclae, but the cost. At Steinbrech’s Alpha Male Plastic Surgery clinic, 25cc of Alloclae can run as high as $5,000. In the case of his pec-lift patient, the cost of the product alone would run $20,000 – and that’s before accounting for the surgeon’s consultation and contact time, plus associated fees. According to Steinbrech’s office, a comparable procedure using autologous fat grafting (liposuction and transfer) would fall in the $10,000–15,000 range. More involved, higher-volume Alloclae procedures could run up to $100,000, just for the fat itself. Unlike comparable treatments, the product faces a natural barrier: more Alloclae demands more donor fat – and more donor bodies.
The people behind Alloclae say costs may come down over time. For now, the high prices and slightly gruesome origins of Alloclae have left some patients feeling bashful. I ask Steinbrech’s Alpha Male patient if, in a few weeks, when he starts getting compliments on his bulkier pecs and rock solid clavicular heads, he will feel comfortable telling people where they came from? He demurs bashfully, saying that he’s a happy person, and that he just wants to look and feel good. Without missing a beat, the doctor jumps in.
“He can say whatever he wants. He can say he went to the gym,” Steinbrech says. “What we want is to have it look natural. So that nobody would even ask that question.”
